Can a simple mouthwash tame the painful side effects of radiation?

NCT ID NCT07748442

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This trial tests two different mouthwashes—benzydamine hydrochloride and super saturated calcium phosphate—to see which better prevents and manages oral mucositis, a painful inflammation of the mouth lining, in head and neck cancer patients receiving radiation therapy. Participants will use one of the mouthwashes during their treatment, and researchers will track the severity of mouth sores weekly. The study also measures a protein in saliva to see if it can predict how severe the mucositis becomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Benzydamine hydrochloride mouthrinse and super saturated calcium phosphate oral rinse
What this could lead to
If successful, this could identify a better mouthwash to reduce the severity of painful mouth sores during radiation therapy, improving quality of life for head and neck cancer patients.
What could go wrong
This is a small early-stage trial, so results may not be conclusive. The effectiveness may vary among individuals, and there is a risk of side effects from the mouthwashes themselves.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Post Graduate Medical Institute, Lahore.

    Lahore, Punjab Province, 54000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.